Thyroid-Stimulating Hormone Receptor Antibodies in Refractory Graves’ Disease Change Differently According to the Type of Definitive Therapy Administered

    OriginalsprogEngelsk
    TidsskriftClinical Thyroidology
    Vol/bind33
    Udgave nummer8
    Sider (fra-til)350-53
    StatusUdgivet - 2021

    Citationsformater